| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/25/2005 | US20050186265 Negatively charged first lipid; barium, calcium, zinc, magnesium and/or cation; carbohydrates, vitamins, minerals, polynucleotides, polypeptides, lipids, flavors and drugs; particle sizes; storage stability, oxidation resistance, dimensional stability; |
| 08/25/2005 | US20050186264 Targeting drug/gene carriers to irradiated tissue |
| 08/25/2005 | US20050186262 Adhesive matrix reservoir affixed to side of backing layer and is comprised of felodipine or isradipine and fatty acid permeation enhancer; solvent-free; hypotensive agents; photosensitive drugs |
| 08/25/2005 | US20050186257 Forming a mixture comprising a water insoluble active ingredient such as caffeine and film-forming ingredients, coating onto a substrate; drying; topical or oral administering by applying to a moist area of individual to release active ingredient; flavor or drug delivery |
| 08/25/2005 | US20050186256 Dissolvable film comprising an active ingredient and method of manufacture |
| 08/25/2005 | US20050186230 Injectable oil-in-water emulsion; less vein irritation; antineoplastic agents |
| 08/25/2005 | US20050186229 Pleasant-tasting aqueous liquid composition of prednisolone sodium phosphate |
| 08/25/2005 | US20050186225 Adenovirus formulations |
| 08/25/2005 | US20050186205 Administering unlabelled anti-CD20 antibody that binds to the CD20 antigen present on lymphoma cells; a second treatment of cyclophosphamide, doxorubicin, vincristine or prednisone |
| 08/25/2005 | US20050186177 Liquid interferon-beta formulations |
| 08/25/2005 | US20050186176 Compounds and compositions for delivering active agents |
| 08/25/2005 | US20050186174 Compositions comprising two different populations of polymer-active agent conjugates |
| 08/25/2005 | US20050186161 Comprises neticonazole and a basic substance; high permeability into nail and also has high efficacy |
| 08/25/2005 | US20050186147 Cosmetic and pharmaceutical foam with solid matter |
| 08/25/2005 | US20050186143 Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation |
| 08/25/2005 | US20050184427 casting matrices comprising a mixture of polymers, solvents and active components selected from drugs, flavors, fragrances, enzymes, preservatives, sweetners, colorants, spices or vitamins, onto wells and drying by applying of heat to form a film dosage unit |
| 08/25/2005 | DE102004006144A1 Formulierungshilfsmittel Formulation auxiliaries |
| 08/25/2005 | CA2819492A1 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 08/25/2005 | CA2559889A1 Targeted atherosclerosis treatment |
| 08/25/2005 | CA2556273A1 Antibody linked cationic emulsions as drug delivery system |
| 08/25/2005 | CA2556254A1 Aqueous solution preparation containing camptothecins |
| 08/25/2005 | CA2555882A1 Controlled release formulations |
| 08/25/2005 | CA2555666A1 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 08/25/2005 | CA2555366A1 Remedy for external use for skin and mucosal injuries caused by viral infection |
| 08/25/2005 | CA2555121A1 Cosmetic and pharmaceutical foam with solid matter |
| 08/25/2005 | CA2554973A1 Particles for inhalation rapid release properties |
| 08/25/2005 | CA2554664A1 Complexed polypeptide and adjuvant for improved vaccines |
| 08/25/2005 | CA2554089A1 Albumin fusion proteins |
| 08/24/2005 | EP1566445A2 Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 08/24/2005 | EP1566179A2 Agent containing fat (oil) which contains onion extract, the production and use thereof |
| 08/24/2005 | EP1566174A2 Flash-melt oral dosage formulation |
| 08/24/2005 | EP1565754A2 New uses of proteins encoded by ble genes and antibiotics from the bleomycin family |
| 08/24/2005 | EP1565230A2 Material compositions and related systems and methods for treating cardiac conditions |
| 08/24/2005 | EP1565217A2 Chemically-modified human growth hormone conjugates |
| 08/24/2005 | EP1565216A1 Nanoparticle conjugates and method of production thereof |
| 08/24/2005 | EP1565208A1 The use of cytochrome p450 enzyme cyp2wi as a drug traget for cancer therapy |
| 08/24/2005 | EP1565205A2 Interferon-alpha polypeptides and conjugates |
| 08/24/2005 | EP1565192A2 Method and compositions for temporarily incapaciting subjets |
| 08/24/2005 | EP1565187A2 Methods of treating cancer and related methods |
| 08/24/2005 | EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 08/24/2005 | EP1565171A2 Controlled absorption of mixed thyroyd hormone formulations |
| 08/24/2005 | EP1565164A2 Self-forming phospholipidic gels |
| 08/24/2005 | EP1565163A2 Emulsive water-soluble concentrates |
| 08/24/2005 | EP1565161A2 Pharmaceutical composition comprising octreotide microparticles |
| 08/24/2005 | EP1565160A2 Administration form for pharmaceutically active peptides with sustained release and method for the production thereof |
| 08/24/2005 | EP1565136A2 Compositions and methods for transdermal oxybutynin therapy |
| 08/24/2005 | EP1565063A1 Use of sweetener acids for the microbiological stabilisation of foodstuffs, cosmetic products, consumer goods and pharmaceutical products |
| 08/24/2005 | EP1497289B1 Medicaments containing betamimetic drugs and a novel anticholinesterase drug |
| 08/24/2005 | EP1401501B1 Oral pharmaceutical compositions with modified release of the active ingredient |
| 08/24/2005 | EP1299349B1 Compounds to treat alzheimer's disease |
| 08/24/2005 | EP1187803B1 Amorphous nitric esters and their pharmaceutical compositions |
| 08/24/2005 | EP1169025B1 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 08/24/2005 | EP1077675B1 Compositions for the treatment of acne |
| 08/24/2005 | EP1030687B1 Cosmetic or dermopharmaceutical composition in the form of hydrophobic beads and methods for preparing same |
| 08/24/2005 | EP1019075B1 Beta 2-adrenergic receptor agonists |
| 08/24/2005 | EP0998271B1 Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs |
| 08/24/2005 | EP0979654B1 Activated vitamin d 3 emulsion-type lotions |
| 08/24/2005 | EP0914102B1 Compositions and methods for treating or preventing diseases of body passageways |
| 08/24/2005 | CN1659288A Method to inhibit cell growth using oligonucleotides |
| 08/24/2005 | CN1659214A Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications |
| 08/24/2005 | CN1658905A Modified byrodin 1 with reduced immunogenicity |
| 08/24/2005 | CN1658902A Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis and therapy |
| 08/24/2005 | CN1658898A Orodispersible pharmaceutical composition comprising perindopril |
| 08/24/2005 | CN1658894A Methods and compositions for the treatment of eye diseases |
| 08/24/2005 | CN1658889A Methods of treating ileus |
| 08/24/2005 | CN1658888A Quaternised ammonium cyclodextrin compounds |
| 08/24/2005 | CN1658887A Novel solid preparation containing block copolymer and anthracycline anticancer agent and process for producing the same |
| 08/24/2005 | CN1658884A Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 08/24/2005 | CN1658882A Use of orally available prostacyclin derivatives for the production of a pharmaceutical agent for treating diseases that are associated with bone marrow edemas |
| 08/24/2005 | CN1658878A Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein |
| 08/24/2005 | CN1658876A A buffered, liquid nicotine composition for pulmonary administration |
| 08/24/2005 | CN1658873A New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 08/24/2005 | CN1658870A Process for preparing a finely self-emulsifiable pharmaceutical composition |
| 08/24/2005 | CN1658862A Process for producing granules containing branched amino acids |
| 08/24/2005 | CN1658861A Novel formate salt of o-desmethyl-venlafaxine |
| 08/24/2005 | CN1658846A 贴剂 Patch |
| 08/24/2005 | CN1658845A Stealth lipid nanocapsules, methods for the preparation thereof, and use thereof as a carrier for active principle(s) |
| 08/24/2005 | CN1658844A Low dose liquid entecavir formulations and use |
| 08/24/2005 | CN1658843A Tablets having improved tabletting characteristics and process for producing the same |
| 08/24/2005 | CN1658840A Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 08/24/2005 | CN1658839A Dry powder compositions |
| 08/24/2005 | CN1658838A Orally disintegrating tablets and process for obtaining them |
| 08/24/2005 | CN1658837A Dry powder inhalant composition |
| 08/24/2005 | CN1658836A Processes for forming a drug delivery device |
| 08/24/2005 | CN1658835A Film-shaped, dissolvable preparations for active substance release and method for the production thereof |
| 08/24/2005 | CN1658834A Method of treating mucus hypersecretion |
| 08/24/2005 | CN1658833A Film-shaped preparations with improved chemical stability containing active substances and method for the production thereof |
| 08/24/2005 | CN1658823A Cosmetic product comprising at least one water-soluble copolymer which contains (meth)acrylamide units |
| 08/24/2005 | CN1658770A Nano-sized self-assembled structured liquids |
| 08/24/2005 | CN1658767A Composition for modulating a physiological reaction or inducing an immune response |
| 08/24/2005 | CN1657100A Nano-class preparation for selective target stomach cancer-and lymph system and its preparation method |
| 08/24/2005 | CN1657041A Skin penetration absorption preparation |
| 08/24/2005 | CN1657040A Curcumin and phosphatide composite and its preparation method |
| 08/24/2005 | CN1215880C Water-soluble matrix for external transdermal paster and preparing method thereof |
| 08/24/2005 | CN1215834C Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion |
| 08/24/2005 | CN1215833C Rapidly disintegrating methylcellulose tablets |
| 08/24/2005 | CN1215831C Chinese medicine cataplasm matrix and preparing technique thereof |
| 08/24/2005 | CN1215828C Synergistic antiplaque/antigivitis oral composition |
| 08/23/2005 | US6933326 fracturing collagen-containing tissue that is acellular and dehydrated and has a basement membrane to which, after rehydration, viable endothelial and epithelial cells attach |
| 08/23/2005 | US6933286 Therapeutic delivery compositions and methods of use thereof |